Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1998-7-9
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0890-9091
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
638, 643
|
pubmed:dateRevised |
2005-6-21
|
pubmed:meshHeading |
pubmed-meshheading:9597675-Antineoplastic Agents, Hormonal,
pubmed-meshheading:9597675-Breast Neoplasms,
pubmed-meshheading:9597675-Estrogen Antagonists,
pubmed-meshheading:9597675-Estrogen Replacement Therapy,
pubmed-meshheading:9597675-Female,
pubmed-meshheading:9597675-Humans,
pubmed-meshheading:9597675-Prognosis,
pubmed-meshheading:9597675-Tamoxifen
|
pubmed:year |
1998
|
pubmed:articleTitle |
Estrogens and women with breast cancer.
|
pubmed:publicationType |
Letter,
Comment
|